Terris D J, Dunphy E P
Division of Otolaryngology/Head and Neck Surgery, University Medical Center, Stanford, Calif.
Arch Otolaryngol Head Neck Surg. 1994 Mar;120(3):283-7. doi: 10.1001/archotol.1994.01880270031006.
There is continued investigation of agents capable of overcoming hypoxic cell radioresistance. The evaluation of tumor oxygenation, therefore, assumes great importance. Previous efforts to measure tumor oxygen tension (PO2) using polarographic methods were limited by the size of the electrodes and efficiency of measurements. A new system employing fine-needle electrodes and a computerized micromanipulator was evaluated.
Prospective study.
Sixteen patients with cancers of the head and neck, seen at Stanford (Calif) University Medical Center and Santa Clara Valley Medical Center, San Jose, Calif, between March 1, 1991, and July 31, 1991. Of the 16 tumors, 14 were squamous cell carcinomas; 11 were previously untreated. In two patients, measurements were repeated during radiation therapy. In three patients, measurements were taken under conditions of varied inspired oxygen during anesthesia. In seven patients, subcutaneous tissue (SQ) measurements were made for comparison.
The mean (+/- SD) PO2 of all tumors was 25.6 +/- 20.2 mm Hg, with a range of 2.3 to 76.4 mm Hg. When only squamous cell carcinomas were considered, the mean tumor PO2 was 22.7 +/- 16.0 mm Hg. The mean SQ measurement was 57.2 +/- 12.8 mm Hg. In all cases (seven of seven) in which SQ data were available, the tumor PO2 was lower than the SQ PO2 by an average of 41.8 mm Hg. The mean tumor PO2 increased in two of three cases of hyperoxia and decreased in the the third. The mean tumor PO2 increased in one patient after 25 Gy of radiotherapy and remained the same in the other.
These measurements suggest that there is significant interindividual variability in the PO2 of head and neck cancers. Squamous cell cancers are generally less well oxygenated than normal SQ tissue. The PO2 histograph identified patients with a low mean tumor PO2.
对能够克服乏氧细胞放射抗性的药物的研究仍在继续。因此,肿瘤氧合评估具有重要意义。以往使用极谱法测量肿瘤氧张力(PO2)受到电极尺寸和测量效率的限制。对一种采用细针电极和计算机化微操作器的新系统进行了评估。
前瞻性研究。
1991年3月1日至1991年7月31日期间在加利福尼亚州斯坦福大学医学中心和加利福尼亚州圣何塞市圣克拉拉谷医疗中心就诊的16例头颈部癌患者。16个肿瘤中,14个为鳞状细胞癌;11个此前未接受过治疗。2例患者在放射治疗期间重复进行了测量。3例患者在麻醉期间在不同吸氧条件下进行了测量。7例患者进行了皮下组织(SQ)测量以作比较。
所有肿瘤的平均(±标准差)PO2为25.6±20.2 mmHg,范围为2.3至76.4 mmHg。仅考虑鳞状细胞癌时,肿瘤平均PO2为22.7±16.0 mmHg。皮下组织平均测量值为57.2±12.8 mmHg。在所有可获得皮下组织数据的病例(7例中的7例)中,肿瘤PO2平均比皮下组织PO2低41.8 mmHg。3例高氧病例中有2例肿瘤平均PO2升高,第3例降低。1例患者在接受25 Gy放射治疗后肿瘤平均PO2升高,另1例保持不变。
这些测量结果表明,头颈部癌的PO2存在显著的个体间差异。鳞状细胞癌的氧合通常不如正常皮下组织。PO2直方图可识别肿瘤平均PO2较低的患者。